Temporal trends in the treatment of relapsing minimal change podocytopathy—a binational cohort study
The treatment of relapses in MCD has changed since 2010 with reduced use of prednisolone monotherapy and cyclophosphamide, and increased use of CNI and rituximab.
Authors
- Rutger Maas (ORCID: https://orcid.org/0000-0002-3006-4916)
- Henrik Birn (ORCID: https://orcid.org/0000-0003-3715-7266)
- Per Ivarsen (ORCID: https://orcid.org/0000-0001-9626-6070)
- Tilde Kristensen (ORCID: https://orcid.org/0000-0002-4009-553X)
Institutions
- Aarhus University (DK)
- Aarhus University Hospital (DK)
- Pathways Behavioral Services (US)
- Regional Hospital Central Jutland (DK)
Publication Details
- Journal
- Nephrology Dialysis Transplantation
- Published
- 2025-04-24
- DOI
- https://doi.org/10.1093/ndt/gfaf072
- Citations
- 1
- Primary Topic
- Renal Diseases and Glomerulopathies
- Type
- article
- Field-Weighted Citation Impact
- 1.43
Funders
- Augustinus Fonden